Science and Technology Committee (Commons)

Genomics and genome-editing inquiry

Inquiry status: open

Accepting written submissions.

Scope of the inquiry

The previous Committee reported on Advanced Genetic techniques for crop improvement: regulation, risk and precaution in February 2015. At the beginning of 2016, the Committee included GM and gene editing in its 'evidence check' process. Genomics England is working towards sequencing 100,000 whole human genomes by the end of 2017, supported by 13 Genomic Medicine Centres. In September 2016 the Nuffield Council on Bioethics published an ethical review on genome editing, looking at the potential issues across human health, food production, wildlife and the ecosystem. The Parliamentary Office for Science and Technology (POST) recently published a POSTnote on genome editing which looks at current and future uses of genome editing, how it is regulated and potential concerns.

Against that background, the Committee has decided to undertake an inquiry into genomics and genome-editing.

 

Terms of reference: Genomics and genome-editing Send a written submission

Latest evidence

  • 08 Feb 2017 - Genomics and genome-editing - oral evidence | PDF version (PDF321 KB) HC 854 | Published 16 Feb 2017

    Evidence given by Professor Sue Hill, Chief Scientific Officer, NHS England, Professor Mark Caulfield, Chief Scientist, Genomics England, and Dr Julia Wilson, Associate Director, Wellcome Trust Sanger Institute; Professor Sir John Burn, Non-executive Director, NHS England, Professor Dame Kay Davies, Non-executive Director, Genomics England, and Dr Helen Firth, Clinical Lead, Deciphering Developmental Disorders Project, Wellcome Trust Sanger Institute

    Watch this evidence session

Next meeting(s)

08 March 2017 9:30 am

Oral Evidence Session

Genomics and genome-editing
View details
Witness(es)

Location

News

Receive RSS updates

Share this page